Talent Risk

Talent Risk · Employers · Pharma & healthcare

BioCryst Pharmaceuticals

American pharmaceutical companyPharma & healthcareHQ US≈435 staff

SignsStepping down: cuts in the last 180 days, nothing new in 90 · since 1st November 2026
Updated 21st November 202626 weeks
47
Jobs in announced cuts · 12 months
10.8%
Of its staff · 12 months
4th Aug 2026
Latest on record

BioCryst Pharmaceuticals is showing signs of job cuts.

Stepping down: cuts in the last 180 days, nothing new in 90. Latest, on 4th August: Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.

This record counts only cuts announced publicly or filed as a formal notice; the everyday redundancies at any large employer are rarely announced and are not here.

How to read this page
  • The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
  • The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
  • Summary says what is happening and what would change the label; Full record lists every report, linked.

What’s happening, and where

No announced or filed job cuts in the last 90 days. The label rests on earlier signs, under Full record.

Next This becomes Cutting if the company, a formal notice or two major outlets confirm cuts.

The last 12 months

DecJanFebMarAprMayJunJulAugSeptOctNov4th Aug 2026: Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.47
CutsBuyouts, plans and signsHiringBigger mark = more jobs named

No cuts found this quarter. We found cuts in 1 of the three quarters before.

This label is our opinion, reached by applying one published rule to the sources listed. BioCryst Pharmaceuticals can correct the record at any time.

At a glance

LabelSigns since the week to 7th Nov
Jobs in announced cuts, 12 months47 · 10.8% of about 435 staff
Latest on the record4th August 2026 · Cuts announced · 47 jobs
Where the jobs areAlabama · Hoover, AL · US
Jobs we countAll 47 jobs reported. How we count
Normal for them?No cuts found this quarter. We found cuts in 1 of the three quarters before.
Sources, 12 months1 formal notice, each linked below
Headquarters · sectorUS · Pharma & healthcare · BCRX

Identifiers Wikidata Q4914611 · LEI 549300Z0INP1Z5NP6J59 · SEC CIK 0000882796 · ISIN US09058V1035 · BCRX on Nasdaq · About these

What happened

Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide

Nothing from BioCryst Pharmaceuticals, a formal notice or a named outlet about its workforce in the last 90 days.

Earlier on the record (1 event, up to a year)
  1. 4th Aug
    BioCryst Pharmaceuticals files a WARN notice for 47 jobs in Alabama

    Cuts announcedAlabamaFormal notice

    Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.

    The source: WARN notice (AL)
    1. 4th Aug

      WARN notice (AL) Official

      Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.

    Its own page, with the facts →

    47jobs cut
Background and commentary (1): in the news, never counted
  1. 4th Nov
    BioCryst Pharmaceuticals: other

    OtherBirminghamFormal notice

    BioCryst Pharmaceuticals reported restructuring costs totalling $15.6 million in Q3 2026, including $6.3 million cash costs and $9.3 million non-cash costs associated with closure of Birmingham site and employee termination costs.

    The source: SEC EDGAR
    1. 4th Nov

      SEC EDGAR Official

      BioCryst Pharmaceuticals reported restructuring costs totalling $15.6 million in Q3 2026, including $6.3 million cash costs and $9.3 million non-cash costs associated with closure of Birmingham site and employee termination costs.

    No figure

In context

How the label has changed · 26 weeks

7th NovCutting → Signs · Stepping down: cuts in the last 180 days, nothing new in 90
8th AugQuiet → Cutting · Confirmed by the company or a formal notice (such as a US WARN notice)

Against its workforce

1 in 9of its staff (11%): 47 job cuts announced in 12 months, against a workforce of about 435.Each square is 1% of BioCryst Pharmaceuticals’s staff

Share of its sector’s cuts

2%

of the 2,796 job cuts announced in 12 months by the employers we rate in pharma & healthcare.

Peers in pharma & healthcare

  1. BioCryst Pharmaceuticals10.8%
  2. GSK1.8%
  3. AstraZeneca0.7%
  4. Novartis0.4%
  5. Novo Nordisk0.4%
  6. Johnson & Johnson0.2%

Job cuts in 12 months as a share of each employer’s workforce.

Use this record RSS · JSON · Embed · Ask an AI ·
Put BioCryst Pharmaceuticals’s label on your site

Two lines show the label and the latest cut, and update themselves. No cookies. About the badge

<div data-talentrisk="biocryst-pharmaceuticals"></div>
<script async src="https://talentrisk.com/embed.js"></script>

Right of reply

BioCryst Pharmaceuticals can reply or correct this record at any time.

Correct the record →

This label is our opinion, reached by applying one published rule to the sources listed.